Silicon Valley's biggest fraud is on trial
axios.com
axios.com
Threads that add nothing new to what has been repetitively discussed countless times are off-topic for HN. When new information appears, then there will be something to discuss.
https://hn.algolia.com/?dateRange=all&page=0&prefix=false&so...
https://hn.algolia.com/?dateRange=all&page=0&prefix=false&so...
Why? I think you shouldn't criticize the child itself but if the woman is bringing it into this world for a nefarious reason like likely playing for a jury's sympathy during a trial, revenge, exploiting immigration loopholes or blackmail. Why shouldn't she be criticized over it? It usually also means that the child will be neglected, in one form or another, after it served its purpose.
Have you ever met a real-life sociopath? I have. Holmes appears a like bona-fide sociopath trying every dirty trick to manipulate her surroundings, playing the "poor woman" card to weasel out of a harsh sentence.
This case wouldn't be prosecuted at all if not for the public scrutiny. The question left largely unanswered was what favors did elizabeth exchange with these old powerful men to get them to first invest and then to become unnindicted coconspirators in her schemes.
And he wasn't on the board. I think it's reasonable to invest seed capital in unproven but interesting ideas, and it's unfair to blame seed investors if those ideas don't pan out.
I would be a lot more embarrassed if I invested 100M into a 10 years old company that turned out to be a fraud vs 500K into a brand new pre-product team.
Phlebotomy is the process of drawing blood, in general medicine typically more like giving lots of or exchanging blood rather than a pin prick or even filling a couple vials for lab work. I worked with an office that was very clear they drew blood for lab work but would not do phlebotomy, I had to have the difference explained to me.
Shouldn’t Axois have specified anyone with hematology, immunology, or serology experience/education?
I don’t think they they SHOULD have had a phlebotomist on their board. That no one had drawn blood before; was the least of Theranos’s problems.
The moral for the legit startups out there is: be super duper clear and intentional with VC and meticulously document all the steps else you might find yourself in lawsuits for misrepresenting this and that to the apparently infallible VC.
What diligence would have saved you? You would have to learn enough about how blood tests work to conclude that it was not likely they had achieved it.
You could have passed on the investment unless they trusted you with the trade secret I suppose.
I’m not saying I have the right answer, but I am saying that it’s not as simple as checking the books.
> Notably, the company told prospective investors in 2014 that the company was on track to break even and generate $100 million in revenue. It brought in little more than $100,000 for that period.
Even if there was no cooking, how can they miss the mark by 1000x? How can VC be like “oh shit we were deceived. They said 100 million and it was 100 thousand.” It’s not rocket science to look at the operations of a company to determine if their claims are off by 1000x.
Edit: spelling.